枸橼酸坦度螺酮

枸橼酸坦度螺酮性质、用途与生产工艺

抗焦虑药

枸橼酸坦度螺酮为第三代新型抗焦虑药，由日本住友制药研制成功，主要作用于大脑边缘系统，对5-HT1A受体具有高度选择性，通过抑制5-HT神经冲动亢进，产生抗焦虑和抗抑郁作用。无依赖、无镇静、肌肉松弛、运动抑制等副作用，具有较好的临床药理特性。适用于各种神经症所致的焦虑状态，如广泛性焦虑症。原发性高血压、消化性溃疡等躯体疾病伴发的焦虑状态。

生物活性

Tandospirone citrate (SM-3997 citrate) 是一种有效的，选择性5-HT1A 受体激动剂 (Ki = 27 nM) , 比作用于 SR-2, SR-1C, α1, α2, D1 和D2受体选择性高(Ki值为1300-41000 nM)。

枸橼酸坦度螺酮 上下游产品信息

上游原料

下游产品

枸橼酸坦度螺酮 试剂级价格

更新日期	产品编号	产品名称	CAS编号	包装	价格
2024/08/19	HY-B0061	枸橼酸坦度螺酮 Tandospirone citrate	112457-95-1	5mg	540元
2024/08/19	HY-B0061	枸橼酸坦度螺酮 Tandospirone citrate	112457-95-1	10mM * 1mLin Water	684元

枸橼酸坦度螺酮 生产厂家

 

112457-95-1, 枸橼酸坦度螺酮 相关搜索:

• API
• 112457-95-1
• 杂质对照品
• 原料药
• 化工品
• 化学试剂
• 生物化工
• C21H29N5O2C6H8O7
• 坦度螺酮-D8 柠檬酸盐
• 4,7-甲甲基-1H-异吲哚-1,3(2H)-二酮,六羟基-2-[4-[4-(2-嘧啶基)-1-哌嗪基]-,(3AR,4S,7R,7AS)-氯化-,2-羟基-1,2,3-丙酸甲酸酯(1:1)
• 柠檬酸坦度螺酮
• REL-(3AR,4S,7R,7AS)-2-(4-(4-(嘧啶-2-基)哌嗪-1-基)丁基)六氢-1H-4,7-甲桥异吲哚-1,3(2H)-二酮 2-羟基丙烷-1,2,3-三羧酸盐
• 坦度螺酮柠檬酸盐
• 枸橼酸坦度螺酮杂质
• 枸橼酸坦度螺酮
• 112457-95-1
• (3aR,4S,7R,7aS)-2-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione 2-hydroxypropane-1,2,3-tricarboxylate
• (3aR,4R,7S,7aS)-2-(4-chlorobutyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
• (3aR,3a'R,4S,4'S,7R,7aS,7'R,7a'S)-2,2'-(piperazine-1,4-diylbis(butane-4,1-diyl))bis(hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione)
• (1S,2R,3S,4R)-3-((4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)carbamoyl)bicyclo[2.2.1]heptane-2-carboxylic acid
• 4-((3aR,4S,7R,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl)butyl 4-(pyrimidin-2-yl)piperazine-1-carboxylate
• 2-(Dicyclohexylphosphanyl)-1-(2-methoxy-6-(triethylsilyl)phenyl)-1H-pyrrole
• SM3997,SM-3997,Tandospirone,Tandospirone citrate,Inhibitor,Serotonin Receptor,SM 3997,5-hydroxytryptamine Receptor,inhibit,5-HT Receptor
• andospironecitrate
• Tandospirone-d8 Citrate
• Tandospirone citrate (SM 3997)
• rel-(3aR,4S,7R,7aS)-2-(4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione 2-hydroxypropane-1,2,3-tricarboxylate
• SM-3997 citrate
• (3aR,4S,7R,7aS)-rel-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
• 3aalpha,4alpha,5,6,7alpha,7aalpha-Hexahydro-2-[4- [4-(2-pyriMidinyl)-1-piperazinyl]butyl]-4,7-Methano-1H-isoindole-1,3(2H)-dione dihydrogen citrate
• Tandopsirone citrate
• Methanospirone
• (3aα,4β,7β,7aα)-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione·citric acid
• tandospirone citrate
• SM 3997
• 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aR,4S,7R,7aS)-rel-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI)
• 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aa,4b,7b,7aa)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)